Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 1683 entries
Sorted by: Best Match Show Resources per page
Pre-operative templating for trauma hemiarthroplasty (Thompson's).

Journal of orthopaedics

Green RN, Rushton PR, Kramer D, Inman D, Partington PF.
PMID: 26566327
J Orthop. 2015 May 29;12(4):248-52. doi: 10.1016/j.jor.2015.05.005. eCollection 2015 Dec.

INTRODUCTION: Surgical complications may be avoided by preoperative templating in trauma hemiarthroplasty.MATERIALS AND METHODS: Digital templates for the Stryker™ range of Thompson's prostheses were created and fifty trauma patients that had undergone cemented hemiarthroplasty were retrospectively templated by 2...

Cite
Green RN, Rushton PR, Kramer D, et al. Pre-operative templating for trauma hemiarthroplasty (Thompson's). J Orthop. 2015;12(4):248-52doi: 10.1016/j.jor.2015.05.005.
Green, R. N., Rushton, P. R., Kramer, D., Inman, D., & Partington, P. F. (2015). Pre-operative templating for trauma hemiarthroplasty (Thompson's). Journal of orthopaedics, 12(4), 248-52. https://doi.org/10.1016/j.jor.2015.05.005
Green, Robert Nicholas, et al. "Pre-operative templating for trauma hemiarthroplasty (Thompson's)." Journal of orthopaedics vol. 12,4 (2015): 248-52. doi: https://doi.org/10.1016/j.jor.2015.05.005
Green RN, Rushton PR, Kramer D, Inman D, Partington PF. Pre-operative templating for trauma hemiarthroplasty (Thompson's). J Orthop. 2015 May 29;12(4):248-52. doi: 10.1016/j.jor.2015.05.005. eCollection 2015 Dec. PMID: 26566327; PMCID: PMC4601989.
Copy Download .nbib Format: NLM
National Cancer Institute-supported clinical trials networks.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Abrams J, Kramer B, Doroshow JH, Varmus H.
PMID: 25452448
J Clin Oncol. 2015 Jan 20;33(3):293. doi: 10.1200/JCO.2014.59.5421. Epub 2014 Dec 01.

No abstract available.

Cite
Abrams J, Kramer B, Doroshow JH, et al. National Cancer Institute-supported clinical trials networks. J Clin Oncol. 2014;33(3):293doi: 10.1200/JCO.2014.59.5421.
Abrams, J., Kramer, B., Doroshow, J. H., & Varmus, H. (2015). National Cancer Institute-supported clinical trials networks. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33(3), 293. https://doi.org/10.1200/JCO.2014.59.5421
Abrams, Jeffrey, et al. "National Cancer Institute-supported clinical trials networks." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 33,3 (2015): 293. doi: https://doi.org/10.1200/JCO.2014.59.5421
Abrams J, Kramer B, Doroshow JH, Varmus H. National Cancer Institute-supported clinical trials networks. J Clin Oncol. 2015 Jan 20;33(3):293. doi: 10.1200/JCO.2014.59.5421. Epub 2014 Dec 01. PMID: 25452448.
Copy Download .nbib Format: NLM
Correction for Zhang et al., Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection.

Infection and immunity

Zhang Z, Chen X, Hernandez LD, Lipari P, Flattery A, Chen SC, Kramer S, Polishook JD, Racine F, Cape H, Kelly CP, Therien AG.
PMID: 26556881
Infect Immun. 2015 Dec;83(12):4899. doi: 10.1128/IAI.01214-15.

No abstract available.

Cite
Zhang Z, Chen X, Hernandez LD, et al. Correction for Zhang et al., Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection. Infect Immun. 2015;83(12):4899doi: 10.1128/IAI.01214-15.
Zhang, Z., Chen, X., Hernandez, L. D., Lipari, P., Flattery, A., Chen, S. C., Kramer, S., Polishook, J. D., Racine, F., Cape, H., Kelly, C. P., & Therien, A. G. (2015). Correction for Zhang et al., Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection. Infection and immunity, 83(12), 4899. https://doi.org/10.1128/IAI.01214-15
Zhang, Z, et al. "Correction for Zhang et al., Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection." Infection and immunity vol. 83,12 (2015): 4899. doi: https://doi.org/10.1128/IAI.01214-15
Zhang Z, Chen X, Hernandez LD, Lipari P, Flattery A, Chen SC, Kramer S, Polishook JD, Racine F, Cape H, Kelly CP, Therien AG. Correction for Zhang et al., Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection. Infect Immun. 2015 Dec;83(12):4899. doi: 10.1128/IAI.01214-15. PMID: 26556881; PMCID: PMC4645384.
Copy Download .nbib Format: NLM
The Acquisition of Target Dependence by Developing Rat Retinal Ganglion Cells.

eNeuro

Moses C, Wheeler LP, LeVaillant CJ, Kramer A, Ryan M, Cozens GS, Sharma A, Pollett MA, Rodger J, Harvey AR.
PMID: 26464991
eNeuro. 2015 Jul 10;2(3). doi: 10.1523/ENEURO.0044-14.2015. eCollection 2015.

Similar to neurons in the peripheral nervous system, immature CNS-derived RGCs become dependent on target-derived neurotrophic support as their axons reach termination sites in the brain. To study the factors that influence this developmental transition we took advantage of...

Cite
Moses C, Wheeler LP, LeVaillant CJ, et al. The Acquisition of Target Dependence by Developing Rat Retinal Ganglion Cells. eNeuro. 2015;2(3)doi: 10.1523/ENEURO.0044-14.2015.
Moses, C., Wheeler, L. P., LeVaillant, C. J., Kramer, A., Ryan, M., Cozens, G. S., Sharma, A., Pollett, M. A., Rodger, J., & Harvey, A. R. (2015). The Acquisition of Target Dependence by Developing Rat Retinal Ganglion Cells. eNeuro, 2(3), . https://doi.org/10.1523/ENEURO.0044-14.2015
Moses, Colette, et al. "The Acquisition of Target Dependence by Developing Rat Retinal Ganglion Cells." eNeuro vol. 2,3 (2015). doi: https://doi.org/10.1523/ENEURO.0044-14.2015
Moses C, Wheeler LP, LeVaillant CJ, Kramer A, Ryan M, Cozens GS, Sharma A, Pollett MA, Rodger J, Harvey AR. The Acquisition of Target Dependence by Developing Rat Retinal Ganglion Cells. eNeuro. 2015 Jul 10;2(3). doi: 10.1523/ENEURO.0044-14.2015. eCollection 2015. PMID: 26464991; PMCID: PMC4586937.
Copy Download .nbib Format: NLM
Adult Hearing Screening: The Cyprus Pilot Program.

Audiology research

Thodi C, Parazzini M, Kramer SE, Davis AC, Stenfelt S, Janssen T, Stephens D, Smith PA, Pronk M, Anteunis LJ, Grandori F.
PMID: 26557302
Audiol Res. 2011 Mar 23;1(1):e18. doi: 10.4081/audiores.2011.e18. eCollection 2011 May 10.

No abstract available.

Cite
Thodi C, Parazzini M, Kramer SE, et al. Adult Hearing Screening: The Cyprus Pilot Program. Audiol Res. 2011;1(1):e18doi: 10.4081/audiores.2011.e18.
Thodi, C., Parazzini, M., Kramer, S. E., Davis, A. C., Stenfelt, S., Janssen, T., Stephens, D., Smith, P. A., Pronk, M., Anteunis, L. J., & Grandori, F. (2011). Adult Hearing Screening: The Cyprus Pilot Program. Audiology research, 1(1), e18. https://doi.org/10.4081/audiores.2011.e18
Thodi, C, et al. "Adult Hearing Screening: The Cyprus Pilot Program." Audiology research vol. 1,1 (2011): e18. doi: https://doi.org/10.4081/audiores.2011.e18
Thodi C, Parazzini M, Kramer SE, Davis AC, Stenfelt S, Janssen T, Stephens D, Smith PA, Pronk M, Anteunis LJ, Grandori F. Adult Hearing Screening: The Cyprus Pilot Program. Audiol Res. 2011 Mar 23;1(1):e18. doi: 10.4081/audiores.2011.e18. eCollection 2011 May 10. PMID: 26557302; PMCID: PMC4627146.
Copy Download .nbib Format: NLM
Interventions after Screening for Hearing Difficulties: A Retrospective Investigation of Interventions other than Hearing Aids.

Audiology research

Stephens D, Gianopoulos I, Kramer SE.
PMID: 26557306
Audiol Res. 2011 Mar 23;1(1):e21. doi: 10.4081/audiores.2011.e21. eCollection 2011 May 10.

No abstract available.

Cite
Stephens D, Gianopoulos I, Kramer SE. Interventions after Screening for Hearing Difficulties: A Retrospective Investigation of Interventions other than Hearing Aids. Audiol Res. 2011;1(1):e21doi: 10.4081/audiores.2011.e21.
Stephens, D., Gianopoulos, I., & Kramer, S. E. (2011). Interventions after Screening for Hearing Difficulties: A Retrospective Investigation of Interventions other than Hearing Aids. Audiology research, 1(1), e21. https://doi.org/10.4081/audiores.2011.e21
Stephens, D, et al. "Interventions after Screening for Hearing Difficulties: A Retrospective Investigation of Interventions other than Hearing Aids." Audiology research vol. 1,1 (2011): e21. doi: https://doi.org/10.4081/audiores.2011.e21
Stephens D, Gianopoulos I, Kramer SE. Interventions after Screening for Hearing Difficulties: A Retrospective Investigation of Interventions other than Hearing Aids. Audiol Res. 2011 Mar 23;1(1):e21. doi: 10.4081/audiores.2011.e21. eCollection 2011 May 10. PMID: 26557306; PMCID: PMC4627168.
Copy Download .nbib Format: NLM
Crystal structure of μ-1κC:2(η(2))-carbonyl-carbonyl-1κC-chlorido-2κCl-μ-chlorido-borylene-1:2κ(2) B:B-[1(η(5))-penta-methyl-cyclo-penta-dien-yl](tri-cyclo-hexyl-phosphane-2κP)iron(II)platinum(II) benzene monosolvate.

Acta crystallographica. Section E, Structure reports online

Braunschweig H, Kramer T.
PMID: 25484763
Acta Crystallogr Sect E Struct Rep Online. 2014 Oct 29;70:421-3. doi: 10.1107/S1600536814023381. eCollection 2014 Nov 01.

In the mol-ecular structure of the dinuclear title compound [η(5)-(C5(CH3)5)(CO)Fe{(μ-BCl)(μ-CO)}PtCl(P(C6H11)3)]·C6H6, the two metal atoms, iron(II) and platinum(II), are bridged by one carbonyl (μ-CO) and one chlorido-borylene ligand (μ-BCl). The Pt(II) atom is additionally bound to a chloride ligand situated...

Cite
Braunschweig H, Kramer T. Crystal structure of μ-1κC:2(η(2))-carbonyl-carbonyl-1κC-chlorido-2κCl-μ-chlorido-borylene-1:2κ(2) B:B-[1(η(5))-penta-methyl-cyclo-penta-dien-yl](tri-cyclo-hexyl-phosphane-2κP)iron(II)platinum(II) benzene monosolvate. Acta Crystallogr Sect E Struct Rep Online. 2014;70:421-3doi: 10.1107/S1600536814023381.
Braunschweig, H., & Kramer, T. (2014). Crystal structure of μ-1κC:2(η(2))-carbonyl-carbonyl-1κC-chlorido-2κCl-μ-chlorido-borylene-1:2κ(2) B:B-[1(η(5))-penta-methyl-cyclo-penta-dien-yl](tri-cyclo-hexyl-phosphane-2κP)iron(II)platinum(II) benzene monosolvate. Acta crystallographica. Section E, Structure reports online, 70421-3. https://doi.org/10.1107/S1600536814023381
Braunschweig, Holger, and Kramer, Thomas. "Crystal structure of μ-1κC:2(η(2))-carbonyl-carbonyl-1κC-chlorido-2κCl-μ-chlorido-borylene-1:2κ(2) B:B-[1(η(5))-penta-methyl-cyclo-penta-dien-yl](tri-cyclo-hexyl-phosphane-2κP)iron(II)platinum(II) benzene monosolvate." Acta crystallographica. Section E, Structure reports online vol. 70 (2014): 421-3. doi: https://doi.org/10.1107/S1600536814023381
Braunschweig H, Kramer T. Crystal structure of μ-1κC:2(η(2))-carbonyl-carbonyl-1κC-chlorido-2κCl-μ-chlorido-borylene-1:2κ(2) B:B-[1(η(5))-penta-methyl-cyclo-penta-dien-yl](tri-cyclo-hexyl-phosphane-2κP)iron(II)platinum(II) benzene monosolvate. Acta Crystallogr Sect E Struct Rep Online. 2014 Oct 29;70:421-3. doi: 10.1107/S1600536814023381. eCollection 2014 Nov 01. PMID: 25484763; PMCID: PMC4257242.
Copy Download .nbib Format: NLM
A model case of a positive outcome in super-super obesity.

Clinical obesity

Hipp A, Kramer M, Gallwitz B, Fritsche A, Zipfel S, Reutershan J, Niess A.
PMID: 25586391
Clin Obes. 2013 Feb;3(1):51-5. doi: 10.1111/cob.12007. Epub 2013 Jan 31.

For an increasing number of obese patients, bariatric surgery is considered as the treatment of choice after the failure of conventional strategies. While numerous studies on bariatric surgery have shown substantial health benefits, there is a broad inter-individual variation...

Cite
Hipp A, Kramer M, Gallwitz B, et al. A model case of a positive outcome in super-super obesity. Clin Obes. 2013;3(1):51-5doi: 10.1111/cob.12007.
Hipp, A., Kramer, M., Gallwitz, B., Fritsche, A., Zipfel, S., Reutershan, J., & Niess, A. (2013). A model case of a positive outcome in super-super obesity. Clinical obesity, 3(1), 51-5. https://doi.org/10.1111/cob.12007
Hipp, A, et al. "A model case of a positive outcome in super-super obesity." Clinical obesity vol. 3,1 (2013): 51-5. doi: https://doi.org/10.1111/cob.12007
Hipp A, Kramer M, Gallwitz B, Fritsche A, Zipfel S, Reutershan J, Niess A. A model case of a positive outcome in super-super obesity. Clin Obes. 2013 Feb;3(1):51-5. doi: 10.1111/cob.12007. Epub 2013 Jan 31. PMID: 25586391.
Copy Download .nbib Format: NLM
Unreported complication of Bravo pH capsule dislodged into the pyriform sinus.

World journal of gastrointestinal endoscopy

Kumar A, Kramer E, Chokhavatia S.
PMID: 25992198
World J Gastrointest Endosc. 2015 May 16;7(5):573-4. doi: 10.4253/wjge.v7.i5.573.

We report an unexpected, previously unreported complication of Bravo pH capsule dislodgement. During Bravo pH testing of a 44-year-old man with gastroesophageal reflux disease, we were unable to endoscopically visualize the capsule attached to the esophageal wall after deployment....

Cite
Kumar A, Kramer E, Chokhavatia S. Unreported complication of Bravo pH capsule dislodged into the pyriform sinus. World J Gastrointest Endosc. 2015;7(5):573-4doi: 10.4253/wjge.v7.i5.573.
Kumar, A., Kramer, E., & Chokhavatia, S. (2015). Unreported complication of Bravo pH capsule dislodged into the pyriform sinus. World journal of gastrointestinal endoscopy, 7(5), 573-4. https://doi.org/10.4253/wjge.v7.i5.573
Kumar, Akash, et al. "Unreported complication of Bravo pH capsule dislodged into the pyriform sinus." World journal of gastrointestinal endoscopy vol. 7,5 (2015): 573-4. doi: https://doi.org/10.4253/wjge.v7.i5.573
Kumar A, Kramer E, Chokhavatia S. Unreported complication of Bravo pH capsule dislodged into the pyriform sinus. World J Gastrointest Endosc. 2015 May 16;7(5):573-4. doi: 10.4253/wjge.v7.i5.573. PMID: 25992198; PMCID: PMC4436927.
Copy Download .nbib Format: NLM
Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients.

OncoTargets and therapy

Niu J, Andres G, Kramer K, Kundranda MN, Alvarez RH, Klimant E, Parikh AR, Tan B, Staren ED, Markman M.
PMID: 26648736
Onco Targets Ther. 2015 Nov 11;8:3323-8. doi: 10.2147/OTT.S92443. eCollection 2015.

BACKGROUND: ESR1 mutation has recently emerged as one of the important mechanisms involved in endocrine resistance. The incidence and clinical implication of ESR1 mutation has not been well evaluated in heavily pretreated breast cancer patients.METHODS: We conducted a retrospective...

Cite
Niu J, Andres G, Kramer K, et al. Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients. Onco Targets Ther. 2015;8:3323-8doi: 10.2147/OTT.S92443.
Niu, J., Andres, G., Kramer, K., Kundranda, M. N., Alvarez, R. H., Klimant, E., Parikh, A. R., Tan, B., Staren, E. D., & Markman, M. (2015). Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients. OncoTargets and therapy, 83323-8. https://doi.org/10.2147/OTT.S92443
Niu, Jiaxin, et al. "Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients." OncoTargets and therapy vol. 8 (2015): 3323-8. doi: https://doi.org/10.2147/OTT.S92443
Niu J, Andres G, Kramer K, Kundranda MN, Alvarez RH, Klimant E, Parikh AR, Tan B, Staren ED, Markman M. Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients. Onco Targets Ther. 2015 Nov 11;8:3323-8. doi: 10.2147/OTT.S92443. eCollection 2015. PMID: 26648736; PMCID: PMC4648593.
Copy Download .nbib Format: NLM
Evaluation of reprocessing medical devices in 14 German regional hospitals and at 27 medical practitioners' offices within the European context - consequences for European harmonization.

GMS hygiene and infection control

Thiede B, Kramer A.
PMID: 24327946
GMS Hyg Infect Control. 2013 Nov 06;8(2):Doc20. doi: 10.3205/dgkh000220. eCollection 2013.

Safe reprocessing of medical devices through cleaning, disinfection, and sterilization is essential for the prevention of health care associated infections (HAI) and to guarantee patient safety. Several studies detected residual contamination and even severe infections of patients, despite carrying...

Cite
Thiede B, Kramer A. Evaluation of reprocessing medical devices in 14 German regional hospitals and at 27 medical practitioners' offices within the European context - consequences for European harmonization. GMS Hyg Infect Control. 2013;8(2):Doc20doi: 10.3205/dgkh000220.
Thiede, B., & Kramer, A. (2013). Evaluation of reprocessing medical devices in 14 German regional hospitals and at 27 medical practitioners' offices within the European context - consequences for European harmonization. GMS hygiene and infection control, 8(2), Doc20. https://doi.org/10.3205/dgkh000220
Thiede, Birgit, and Kramer, Axel. "Evaluation of reprocessing medical devices in 14 German regional hospitals and at 27 medical practitioners' offices within the European context - consequences for European harmonization." GMS hygiene and infection control vol. 8,2 (2013): Doc20. doi: https://doi.org/10.3205/dgkh000220
Thiede B, Kramer A. Evaluation of reprocessing medical devices in 14 German regional hospitals and at 27 medical practitioners' offices within the European context - consequences for European harmonization. GMS Hyg Infect Control. 2013 Nov 06;8(2):Doc20. doi: 10.3205/dgkh000220. eCollection 2013. PMID: 24327946; PMCID: PMC3857276.
Copy Download .nbib Format: NLM
Observation of Wakefields and Resonances in Coherent Synchrotron Radiation.

Physical review letters

Billinghurst BE, Bergstrom JC, Baribeau C, Batten T, Dallin L, May TE, Vogt JM, Wurtz WA, Warnock R, Bizzozero DA, Kramer S.
PMID: 26047232
Phys Rev Lett. 2015 May 22;114(20):204801. doi: 10.1103/PhysRevLett.114.204801. Epub 2015 May 20.

We report on high resolution measurements of resonances in the spectrum of coherent synchrotron radiation (CSR) at the Canadian Light Source (CLS). The resonances permeate the spectrum at wave number intervals of 0.074  cm(-1), and are highly stable under...

Cite
Billinghurst BE, Bergstrom JC, Baribeau C, et al. Observation of Wakefields and Resonances in Coherent Synchrotron Radiation. Phys Rev Lett. 2015;114(20):204801doi: 10.1103/PhysRevLett.114.204801.
Billinghurst, B. E., Bergstrom, J. C., Baribeau, C., Batten, T., Dallin, L., May, T. E., Vogt, J. M., Wurtz, W. A., Warnock, R., Bizzozero, D. A., & Kramer, S. (2015). Observation of Wakefields and Resonances in Coherent Synchrotron Radiation. Physical review letters, 114(20), 204801. https://doi.org/10.1103/PhysRevLett.114.204801
Billinghurst, B E, et al. "Observation of Wakefields and Resonances in Coherent Synchrotron Radiation." Physical review letters vol. 114,20 (2015): 204801. doi: https://doi.org/10.1103/PhysRevLett.114.204801
Billinghurst BE, Bergstrom JC, Baribeau C, Batten T, Dallin L, May TE, Vogt JM, Wurtz WA, Warnock R, Bizzozero DA, Kramer S. Observation of Wakefields and Resonances in Coherent Synchrotron Radiation. Phys Rev Lett. 2015 May 22;114(20):204801. doi: 10.1103/PhysRevLett.114.204801. Epub 2015 May 20. PMID: 26047232.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 1683 entries